Glutathione

Specifications

70-18-8CAS Number

200-725-4EC Number

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acidIUPAC Name

C10H17N3O6SChemical Formula

307.33 g/molMolecular Weight

glutathione; 70-18-8; L-Glutathione reduced; L-Glutathione; Glutathion; Isethion; reduced glutathione; Tathion; Glutinal; Glutathione-SH; Deltathione; Copren; Neuthion; Tathione; Glutide; Triptide; Glutatione; Ledac; Glutatiol; Panaron; Agifutol S; Glutathione (reduced); L-gamma-glutamyl-L-cysteinylglycine; Glutathione SH; gamma-L-Glutamyl-L-cysteinylglycine; 5-L-Glutamyl-L-cysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; Glutham; DTXSID6023101; Glycine, L-gamma-glutamyl-L-cysteinyl-; Reduced l-glutathione; N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine; Aec glutathione; N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine; GAN16C9B8O; glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)-; (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid; (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid; NSC-400639; DTXCID903101; CHEBI:16856; glutathionate; Glutathione, Reduced; NSC400639; gamma L Glu L Cys Gly; gamma-L-Glu-L-Cys-Gly; Glutathione 2%; (2S)-2-amino-4-(((1R)-1-((carboxymethyl)carbamoyl)-2-sulfanylethyl)carbamoyl)butanoic acid; Brain Rhabilitation; (2S)-2-amino-5-(((2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl)amino)-5-oxopentanoic acid; gamma L Glutamyl L Cysteinylglycine; Brain Rehabilitation; Knuckle WhiteningLotion; RefChem:5864; Knuckle Whitening Lotion; K2LTS Brain Rhabilitation; K2LTS Brain Rehabilitation; GZE Glutathione BrighteningSoap; COLLAGEN XTRA WHITE SERUM; HARUTO HANGOVER DEFENCEPATCH; (2S)-2-Amino-4-(1-(carboxymethyl)carbamoyl-(2R)-2-sulfanylethylcarbamoyl)butanoic acid; (2S)-2-azaniumyl-5-(((2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl)amino)-5-oxopentanoate; 200-725-4; GSH; glutathione reduced; L-Glutatione; L-Glutathione, reduced; Glutathione [JAN]; MFCD00065939; (S)-2-Amino-5-(((R)-1-((carboxymethyl)amino)-3-mercapto-1-oxopropan-2-yl)amino)-5-oxopentanoic acid; C10H17N3O6S; gamma-L-Glutamylcysteinylglycine; glutathione red; red. glutathione; Bakezyme RX; gamma-Glutamylcysteinylglycine; L-Glutathione (reduced form); L-Glutathione reduce; GLUTATHIONE, L-; L-glutamyl-L-cysteinylglycine; 95687-20-0; BenzenaMine, 2-[(4-Methoxyphenyl)Methoxy]-; 106272-20-2; [Glu(-Cys)]n-Gly; FG10640; CAS-70-18-8; Glutathione reduced form; CCRIS 2094; Glutathione; l-gamma-Glutamyl-l-cysteinylglycine; SR-05000002567; Glutathione [BAN:JAN]; EINECS 200-725-4; L-gamma-glutamyl-L-cysteinyl-glycine; L-Glutathione reduced form; UNII-GAN16C9B8O; NSC 400639; ReadiSorb; Glutathione CRS; Glutathione/GSH; 1lbk; NCGC00094976-01; gamma-Glu-Cys-Gly; Glu(Cys-Gly); Tathion (TN); Glutathione (JP18); Spectrum_000419; 1oe7; 1oe8; 1r4w; C(N-.gamma.Glu-)G; Glycine, L-.gamma.-glutamyl-L-cysteinyl-; GLUTATHIONE [II]; GLUTATHIONE [MI]; Spectrum2_001500; Spectrum3_000946; Spectrum4_001056; Spectrum5_000940; ?-Glutamylcysteinylglycine; Glutathione, Reduced Form; bmse000185; bmse000952; bmse000956; Glutathione (Reduced type); GLUTATHIONE [VANDF]; Cys(N-.gamma.Glu-)-Gly; SCHEMBL9167; CHEMBL1543; GLUTATHIONE [MART.]; GLUTATHIONE [USP-RS]; GLUTATHIONE [WHO-DD]; KBioGR_001352; KBioSS_000899; MLS001333069; DivK1c_000075; SPECTRUM1502248; SPBio_001519; gamma-glutamyl-cysteinyl-glycine; GTPL6737; L-Glutathione, reduced (GSH); SCHEMBL1384624; ?-L-Glutamyl-L-cysteinylglycine; L-?-glutamyl-L-cysteinylglycine; L-Glutathione reduced, 97.0%; HMS500D17; KBio1_000075; KBio2_000899; KBio2_003467; KBio2_006035; KBio3_002012; (gamma-Glutamylcysteine)n-glycine; Glutathione Reduced(GSH Reduced); L-g-glutamyl-L-cysteinyl-glycine; MSK8304; ?-L-Glutamyl-L-cysteinyl-glycine; L-|_-Glutamyl-L-cysteinylglycine; NINDS_000075; GLUTATHIONE [EP MONOGRAPH]; GLXC-21963; HMS1921N22; Pharmakon1600-01502248; HY-D0187; L-Glutathione reduced, >=98.0%; Tox21_111371; BDBM50422268; CCG-38876; EBC-02054; NSC758199; s4606; AKOS015999135; N5-((R)-1-((carboxymethyl)amino)-3-mercapto-1-oxopropan-2-yl)-L-glutamine; Tox21_111371_1; CS-7948; DB00143; FG61468; NSC-758199; SDCCGMLS-0066687.P001; .gamma.-L-Glutamyl-L-cysteinyl-glycine; IDI1_000075; N-(N-L-?-Glutamyl-L-cysteinyl)glycine; Pharm Biol 11: 539 (1968); SMP1_000247; NCGC00264046-02; DS-14675; SMR000857220; ST097777; SY012937; n-(n-l-gamma-glutamyl-l-cysteinyl)-glycin; SBI-0051743.P002; L-Glutathione reduced, BioXtra, >=98.0%; L-Glutathione, reduced, tested to USP spec; G0074; Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl); N-(N-L-.gamma.-Glutamyl-L-cysteinyl)glycine; C00051; C02471; D00014; EN300-311690; G-3980; P19615; AB00443568_03; Glutathione 100 microg/mL in Acetonitrile:Water; F213215; Q116907; SR-05000002567-1; SR-05000002567-2; BRD-K69346723-001-04-8; L-Glutathione reduced, Vetec(TM) reagent grade, >=98%; Z2183947556; Glutathione, European Pharmacopoeia (EP) Reference Standard; Glutathione, United States Pharmacopeia (USP) Reference Standard; Glutathione, Pharmaceutical Secondary Standard; Certified Reference Material; L-Glutathione reduced, cell culture tested, BioReagent, >=98.0%, powder; GSH;Glu(Cys-Gly);?-L-Glutamyl-L-Cysteinyl-Glycine;5-L-Glutamyl-L-cysteinylglycine; (2S)-2-amino-5-[[(1R)-2-(carboxymethylamino)-2-oxo-1-(sulfanylmethyl)ethyl]amino]-5-oxo-pentanoic acid; (S)-2-Amino-5-((R)-1-(carboxymethylamino)-3-mercapto-1-oxopropan-2-ylamino)-5-oxopentanoic acid; 4-(N-{(1R)-1-[N-(carboxymethyl)carbamoyl]-2-sulfanylethyl}carbamoyl)(2S)-2-ami nobutanoic acid; glutathione; l-glutathione reduced; 5-l-glutamyl-l-cysteinylglycine; gamma-l-glutamyl-l-cysteinylglycine; gshSynonyms